Daniel H. Nebdal

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

FGFR1 suppresses STING-mediated interferon response in endocrine therapy resistant breast cancer.

FGFR1 suppresses STING-mediated interferon response in endocrine therapy resistant breast cancer.

Journal: Cancer research communications

Published: January 12, 2026

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab.

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab.

Journal: Frontiers in oncology

Published: August 07, 2025

Elevated KRAS protein level is associated with better survival in pancreatic cancer.

Elevated KRAS protein level is associated with better survival in pancreatic cancer.

Journal: BMC cancer

Published: April 27, 2025

Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool.

Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool.

Journal: Nature communications

Published: February 14, 2025

Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study.

Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study.

Journal: Gynecologic oncology

Published: December 06, 2024

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations.

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations.

Journal: Virchows Archiv : an international journal of pathology

Published: July 06, 2024

Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease.

Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease.

Journal: BMC cancer

Published: December 04, 2023

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome.

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome.

Journal: Cancer research communications

Published: October 23, 2021

Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor.

Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor.

Journal: Molecular oncology

Published: May 28, 2021

Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.

Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 28, 2020

Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC.

Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC.

Journal: Molecular oncology

Published: May 28, 2019

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.

Journal: Molecular oncology

Published: March 01, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026